PHARM
|Pharming Group NV
AS
EUR 0.86
-0.00|-0.46%
Current Price
EUR 0.86
Change
EUR -0.00 (-0.46%)
P/E Ratio
Dividend Yield
Market Cap
713.34M
Volume
2.81M
Open
EUR 0.87
Previous Close
EUR 0.86
52-Week High
EUR 1.10
52-Week Low
EUR 0.65
About Pharming Group NV
Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company's lead product is RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3K" inhibitor for the treatment of activated pho...
Sector:Healthcare
Industry:Biotechnology
CEO:Mr. Fabrice Chouraqui Ph.D., Pharm.D.
Employees:404
Headquarters:Leiden, Netherlands
Website:www.pharming.com
Similar Companies
Explore Stocks by Sector
technology
finance
healthcare
Frequently Asked Questions